Stephen J. Forman
2022
In 2022, Stephen J. Forman earned a total compensation of $85.8K as Director at LIXTE BIOTECHNOLOGY HOLDINGS, a 81% decrease compared to previous year.
Compensation breakdown
| Option Awards | $63,340 |
|---|---|
| Other | $22,500 |
| Total | $85,840 |
Forman received $63.3K in option awards, accounting for 74% of the total pay in 2022.
Forman also received $22.5K in other compensation.
Rankings
In 2022, Stephen J. Forman's compensation ranked 5,628th out of 5,760 executives tracked by ExecPay. In other words, Forman earned more than 2.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,628 out of 5,760 | 2nd |
Division Manufacturing | 3,070 out of 3,136 | 2nd |
Major group Chemicals And Allied Products | 1,396 out of 1,422 | 2nd |
Industry group Drugs | 1,303 out of 1,323 | 2nd |
Industry Pharmaceutical Preparations | 952 out of 969 | 2nd |
Source: SEC filing on November 4, 2024.
Forman's colleagues
We found six more compensation records of executives who worked with Stephen J. Forman at LIXTE BIOTECHNOLOGY HOLDINGS in 2022.
2022
Bas der Baan
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
René Bernards
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Yun Yen
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Regina Brown
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Philip Palmedo
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Gil Schwartzberg
LIXTE BIOTECHNOLOGY HOLDINGS